Search Results

Efficacy, safety, and current applications of brimonidine

Authors: Fudemberg, Scott J; Batiste, Corey; Katz, L Jay

Source: Expert Opinion on Drug Safety, Volume 7, Number 6, November 2008 , pp. 795-799(5)

Publisher: Informa Healthcare

Comparison of allergy rates in glaucoma patients receiving brimonidine 0.2% monotherapy versus fixed-combination brimonidine 0.2%-timolol 0.5% therapy

Author: Motolko, Michael A.

Source: Current Medical Research and Opinion, Volume 24, Number 9, September 2008 , pp. 2663-2667(5)

Publisher: Informa Healthcare

Brimonidine-purite 0.1% versus brimonidine-purite 0.15% twice daily in glaucoma or ocular hypertension: a 12-month randomized trial

Authors: Cantor, Louis B.; Safyan, Eleonora; Liu, Ching-Chi; Batoosingh, Amy L.

Source: Current Medical Research and Opinion, Volume 24, Number 7, July 2008 , pp. 2035-2043(9)

Publisher: Informa Healthcare

Non-systemic delivery of topical brimonidine to the brain: A neuro-ocular tissue distribution study

Authors: Tamilvanan, Shunmugaperumal; Abdulrazik, Muhammad; Benita, Simon

Source: Journal of Drug Targeting, Volume 14, Number 10, December 2006 , pp. 670-679(10)

Publisher: Informa Healthcare

Polycarboxylic acid nanoparticles for ophthalmic drug delivery: an ex vivo evaluation with human cornea

Authors: De T. K.; Bergey E. J.; Chung S. J.; Rodman D. J.; Bharali D. J.; Prasad P. N.

Source: Journal of Microencapsulation, Volume 21, Number 8, December 2004 , pp. 841-855(15)

Publisher: Informa Healthcare

Miotic effect of alphagan P

Author: Faulkner W.

Source: Journal of Cataract and Refractive Surgery, Volume 29, Number 3, March 2003 , pp. 423-423(1)

Publisher: Elsevier

Quantitation of mitomycin C in human ocular tissues by high-performance liquid chromatography-photo-diode array detection

Authors: Xiong X.; Lim B.A.; Lat-Luna M.; Chew P.; Tan D.

Source: Journal of Chromatography B: Biomedical Sciences and Applications, Volume 755, Number 1, 5 May 2001 , pp. 65-72(8)

Publisher: Elsevier

The evolving pharmacotherapeutic profile of brimonidine, an 2-adrenergic agonist, after four years of continuous use

Author: Cantor L.B.

Source: Expert Opinion on Pharmacotherapy, Volume 1, Number 4, May 2000 , pp. 815-834(20)

Publisher: Informa Healthcare

An atomic force microscopy study of a temperature dependent morphology transition of GaN grown on sapphire by MOCVD

Authors: de Theije F.K.; Zauner A.R.A.; Hageman P.R.; van Enckevort W.J.P.; Larsen P.K.

Source: Journal of Crystal Growth, Volume 197, Number 1, 1 February 1999 , pp. 37-47(11)

Publisher: Elsevier

Cost considerations of medical therapy for glaucoma - effects of treating for 1 year and of switching from timolol

Authors: Fiscella R.G.; Geller J.L.; Gryz L.L.; Wilensky J.; Viana M.

Source: American Journal of Ophthalmology, Volume 128, Number 4, October 1999 , pp. 426-433(8)

Publisher: Elsevier